High Tower Advisors, LLC Biogen Inc. Transaction History

High Tower Advisors, LLC

$64.2 Billion
Q2 2024

A detailed history of High Tower Advisors, LLC transactions in Biogen Inc. stock. As of the latest transaction made, High Tower Advisors, LLC holds 13,767 shares of BIIB stock, worth $2.39 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

13,767

Previous 14,040 1.94%

Holding current value

$2.39 Million

Previous $3.03 Million 5.42%

% of portfolio

0.0%

Previous 0.0%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$190.52 - $236.72 $52,011 - $64,624	-273 Reduced 1.94%	13,767 $3.19 Million
Q1 2024 May 06, 2024	BUY	$212.02 - $267.71 $65,514 - $82,722	309 Added 2.25%	14,040 $3.03 Million
Q4 2023 Feb 12, 2024	BUY	$222.59 - $267.94 $215,689 - $259,633	969 Added 7.59%	13,731 $3.55 Million
Q3 2023 Nov 08, 2023	SELL	$253.3 - $285.89 $1.21 Million - $1.37 Million	-4,792 Reduced 27.3%	12,762 $3.28 Million
Q2 2023 Aug 14, 2023	SELL	$275.25 - $318.06 $8,257 - $9,541	-30 Reduced 0.17%	17,554 $5 Million
Q1 2023 May 11, 2023	SELL	$256.56 - $292.34 $2.14 Million - $2.43 Million	-8,323 Reduced 32.13%	17,584 $4.89 Million
Q4 2022 Feb 08, 2023	BUY	$252.44 - $306.72 $1.52 Million - $1.85 Million	6,016 Added 30.24%	25,907 $7.17 Million
Q3 2022 Nov 09, 2022	SELL	$194.69 - $268.46 $2.26 Million - $3.11 Million	-11,597 Reduced 36.83%	19,891 $5.31 Million
Q2 2022 Aug 10, 2022	BUY	$187.54 - $223.02 $3.64 Million - $4.33 Million	19,427 Added 161.07%	31,488 $6.42 Million
Q1 2022 May 12, 2022	SELL	$193.77 - $244.14 $390,059 - $491,453	-2,013 Reduced 14.3%	12,061 $2.54 Million
Q4 2021 Feb 10, 2022	SELL	$223.92 - $287.77 $1.18 Million - $1.52 Million	-5,271 Reduced 27.25%	14,074 $3.36 Million
Q3 2021 Nov 12, 2021	BUY	$282.99 - $369.05 $108,951 - $142,084	385 Added 2.03%	19,345 $5.48 Million
Q2 2021 Aug 06, 2021	SELL	$259.0 - $414.71 $5.02 Million - $8.05 Million	-19,400 Reduced 50.57%	18,960 $6.57 Million
Q1 2021 May 10, 2021	SELL	$242.95 - $284.63 $30,125 - $35,294	-124 Reduced 0.32%	38,360 $10.8 Million
Q4 2020 Feb 10, 2021	BUY	$236.26 - $355.63 $3.02 Million - $4.55 Million	12,795 Added 49.81%	38,484 $9.37 Million
Q3 2020 Nov 13, 2020	BUY	$264.77 - $305.71 $1.59 Million - $1.84 Million	6,023 Added 30.63%	25,689 $7.32 Million
Q2 2020 Aug 10, 2020	SELL	$258.66 - $342.55 $852,026 - $1.13 Million	-3,294 Reduced 14.35%	19,666 $5.27 Million
Q1 2020 May 21, 2020	SELL	$268.85 - $341.04 $509,201 - $645,929	-1,894 Reduced 7.62%	22,960 $7.24 Million
Q4 2019 Feb 14, 2020	BUY	$220.06 - $304.07 $230,402 - $318,361	1,047 Added 4.4%	24,854 $7.39 Million
Q3 2019 Nov 12, 2019	BUY	$217.44 - $243.88 $1.29 Million - $1.44 Million	5,915 Added 33.06%	23,807 $5.52 Million
Q2 2019 Aug 13, 2019	SELL	$219.29 - $241.72 $3.08 Million - $3.4 Million	-14,066 Reduced 44.01%	17,892 $4.19 Million
Q1 2019 May 15, 2019	SELL	$216.71 - $338.96 $1.01 Million - $1.58 Million	-4,673 Reduced 12.76%	31,958 $7.56 Million
Q4 2018 Feb 14, 2019	BUY	$278.5 - $352.75 $921,835 - $1.17 Million	3,310 Added 9.93%	36,631 $11 Million
Q3 2018 Nov 09, 2018	BUY	$293.51 - $383.83 $253,299 - $331,245	863 Added 2.66%	33,321 $11.7 Million
Q2 2018 Aug 14, 2018	BUY	$257.52 - $306.91 $4.73 Million - $5.64 Million	18,366 Added 130.33%	32,458 $9.42 Million
Q1 2018 May 15, 2018	SELL	$260.13 - $367.91 $2.32 Million - $3.29 Million	-8,937 Reduced 38.81%	14,092 $3.86 Million
Q4 2017 Feb 14, 2018	SELL	$307.64 - $344.58 $2.59 Million - $2.9 Million	-8,405 Reduced 26.74%	23,029 $7.33 Million
Q3 2017 Nov 14, 2017	BUY	$281.15 - $329.69 $629,213 - $737,846	2,238 Added 7.67%	31,434 $9.84 Million
Q2 2017 Aug 14, 2017	BUY	N/A	29,196	29,196 $7.92 Million

Others Institutions Holding BIIB

# of Institutions

1,018

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Tower Advisors, LLC with notifications on news.

Account

High Tower Advisors, LLC Biogen Inc. Transaction History